Details for New Drug Application (NDA): 020221

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 020221 describes ETHYOL, which is a drug marketed by Clinigen and is included in one NDA. It is available from one supplier. Additional details are available on the ETHYOL profile page.

The generic ingredient in ETHYOL is amifostine. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amifostine profile page.

Summary for 020221

Tradename:	ETHYOL
Applicant:	Clinigen
Ingredient:	amifostine
Patents:	0
Formulation / Manufacturing:	see details

Pharmacology for NDA: 020221

Mechanism of Action	Free Radical Scavenging Activity

Medical Subject Heading (MeSH) Categories for 020221

Radiation-Protective Agents

Suppliers and Packaging for NDA: 020221

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ETHYOL	amifostine	INJECTABLE;INJECTION	020221	NDA	Clinigen Limited	76310-017	76310-017-50	3 VIAL, SINGLE-USE in 1 CARTON (76310-017-50) / 10 mL in 1 VIAL, SINGLE-USE (76310-017-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	500MG/VIAL
Approval Date:	Dec 8, 1995	TE:	AP	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	375MG/VIAL
Approval Date:	Sep 10, 1999	TE:		RLD:	No

Expired US Patents for NDA 020221

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Clinigen	ETHYOL	amifostine	INJECTABLE;INJECTION	020221-002	Sep 10, 1999	See Plans and Pricing	See Plans and Pricing
Clinigen	ETHYOL	amifostine	INJECTABLE;INJECTION	020221-001	Dec 8, 1995	See Plans and Pricing	See Plans and Pricing
Clinigen	ETHYOL	amifostine	INJECTABLE;INJECTION	020221-001	Dec 8, 1995	See Plans and Pricing	See Plans and Pricing
Clinigen	ETHYOL	amifostine	INJECTABLE;INJECTION	020221-001	Dec 8, 1995	See Plans and Pricing	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.